Veerhealth Care, a company in the Pharmaceuticals industry, reported revenue of ₹22 crore and net profit of ₹1.21 crore for the September 2026 quarter.
Veerhealth Care (BSE: VEERHEALTH) closed at ₹58.45 on 20 Nov 2026, up 229.7% over the past year. Its market capitalisation is ₹117 crore and it trades at 51.5 times earnings.
Incorporated in 1992, Veer Healthcare Ltd is in the business of trading, manufacturing and marketing research based ayurvedic medicines
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.